Reaffirming its fiscal 2024 EPS guidance suggests Cardinal Health is confident in its financial stability and growth prospects. This positive outlook is likely to reassure investors and could lead to a short-term positive impact on the stock price, especially since the guidance aligns with consensus estimates, indicating that the company's performance is in line with market expectations.